1. Home
  2. PHAT vs CGBD Comparison

PHAT vs CGBD Comparison

Compare PHAT & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.61

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$10.99

Market Cap

826.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAT
CGBD
Founded
2018
2012
Country
United States
United States
Employees
N/A
2500
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
894.0M
826.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PHAT
CGBD
Price
$11.61
$10.99
Analyst Decision
Strong Buy
Hold
Analyst Count
6
8
Target Price
$19.83
$12.92
AVG Volume (30 Days)
1.4M
598.3K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
14.42%
EPS Growth
42.72
N/A
EPS
N/A
N/A
Revenue
$175,110,000.00
N/A
Revenue This Year
$93.04
$3.74
Revenue Next Year
$58.91
$1.80
P/E Ratio
N/A
$10.36
Revenue Growth
216.93
N/A
52 Week Low
$3.70
$10.64
52 Week High
$18.31
$14.32

Technical Indicators

Market Signals
Indicator
PHAT
CGBD
Relative Strength Index (RSI) 45.68 39.63
Support Level $11.04 $10.68
Resistance Level $13.03 $12.17
Average True Range (ATR) 0.79 0.29
MACD -0.13 -0.10
Stochastic Oscillator 20.09 12.48

Price Performance

Historical Comparison
PHAT
CGBD

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: